Yes. We keep the systems behind prior authorization running smoothly, including reliable access to payer portals, specialty pharmacy platforms, and the oncology EHR fields that drive approvals for high-cost drugs. Faster, more stable access means fewer delays getting expensive chemotherapy, immunotherapy, and oral oncolytics approved and delivered to the patient.